BE2012 a novel, REV-ERB antagonist that promotes regenerative myogenesis in vivo with substantially improved pharmacokinetics relative to SR8278.

cobramine (CB-6) - Celtic Biotech

http://www.ncbi.nlm.nih.gov/pubmed/42700644

Aurore C Valfort; Bahaa Elgendy; Feng Yue; Isabelle Côté; Lingaiah Maram; Matthew E Hayes; Rhea Arya; Ryan K Sanders; Sheryl L Burris; Thomas P Burris

Sep 6, 2026